The expression and role of PIDD in retina after optic nerve crush
The expression and role of PIDD in retina after optic nerve crush
复制标题
视神经挤压伤后视网膜PIDD的表达及作用
DOI:
10.1007/s10735-020-09860-1
复制
发表时间:
2020
影响因子:
3.2
通讯作者:
Mingyuan Zhang
中科院分区:
文献类型:
--
作者:
Fen Tang;Fan Xu;Ling Cui;Wei Huang;Li Jiang;Lifei Chen;Wenya Yan;Wenjing He;Chaolan Shen;Hui Huang;Jian Lv;Xin Zhao;Siming Zeng;Min Li;Yiqiang Ouyang;Xiaoping Guo;Haibin Zhong;Mingyuan Zhang
To examine the expression of P53-induced protein with a death domain (PIDD) at retina in animal model of optic nerve crush (ONC) and to investigate the role of PIDD in retinal glial activation and NF-κB activation induced by optic nerve damage, ONC animal model was established in Sprague–Dawley rats. PIDD has three isoforms (Isof); Western blot was performed to examine the expression of PIDD (Isof-1, Isof-2, and Isof-3, respectively) in retina at different time points after ONC. Retinal glial activation is closely associated with retinal neuronal death and is monitored by the expression of GFAP+ glial cells and IBA1+ microglia, then activated microglia leads to inflammatory cytokine production. NF-kB activation in glial cells also can promote neuronal death. In our study, the role of PIDD in retinal glial activation and NF-kB activation was investigated with PIDD inhibition selectively. PIDD expression (Isof-1 and Isof-3) was dramatically increased, and peaked at 3 days after ONC, while Isof-2 did not show any difference. In the ONC animal model, the number of GFAP+ glial cells and IBA1+ microglia in retinal layers was increased significantly, inflammatory cytokine production was upregulated, and NF-κB in glial cell was also activated. Moreover, those responses induced by optic nerve damage were attenuated with PIDD inhibition, which indicated that PIDD could regulate retinal glial activation, neuro-inflammation, and NF-κB activation. These results provided the direct demonstration that the PIDD (Isof-1and Isof-3) was overexpressed in retina after ONC, and PIDD may be involved in retinal neurodegenerative diseases by regulating retinal glial activation and NF-κB activation.